Operating cash flow
Flow – sum over the period · $M
Q4 2024
39.7a$M
derived
All values (14)
| Period | Value ($M) | Status |
|---|---|---|
| Q2 2026 | 87.7 | derived |
| Q1 2026 | 74.6 | reported |
| Q4 2025 | 95.3 | derived |
| Q3 2025 | 78.2 | derived |
| Q2 2025 | 135.4 | derived |
| Q1 2025 | 10.5 | reported |
| Q4 2024 | 39.7 | derived |
| Q3 2024 | 63.5 | derived |
| Q2 2024 | 29.8 | derived |
| Q1 2024 | 3.7 | reported |
| Q4 2023 | 14.4 | derived |
| Q3 2023 | −0.3 | derived |
| Q2 2023 | −23.0 | derived |
| Q1 2023 | −3.8 | reported |
| Q1 2016 – Q4 2022 | – | missing (28 periods): No verified SEC value extracted, although the company reports this metric in other periods. |
Show reported periods only · CSV with all sources · Technical ID: ocf
More metrics for Astera Labs
Income statement
Balance sheet
Revenue by segment/product/region
Sources & calculation
- Value
- $40.0M (derived)
- Period
- Q4 2024, ended Dec 31, 2024 · quarterly value (3 months, not cumulative)
- Calculation
- Q4 = fiscal year − 9 months cumulative = 137M − 97M = $40.0M (FY value from 10-K 0001736297-26-000010; 9-month value from the Q3-10-Q)
- Source
- 10-K, filed Feb 20, 2026 · 0001736297-26-000010
- Location
- us-gaap:NetCashProvidedByUsedInOperatingActivities
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $40.0M | Feb 20, 2026 | 10-K 0001736297-26-000010 | derived · confidence 1. · current |